Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Trading Statement

13 Apr 2021 07:00

RNS Number : 2105V
De La Rue PLC
13 April 2021
 

13 April 2021

DE LA RUE PLC

TRADING UPDATE

De La Rue plc (LSE: DLAR) ("De La Rue" or the "Company") today announces a trading update for financial year 2020/21, which ended 27 March 2021.

 

As a result of continued positive trading, the Board expects Adjusted Operating Profit for the financial year 2020/21 to be around the top end of the £36 million to £37 million range previously indicated in the Company's trading update of 28 January 2021.

End of year Net Debt was approximately £53 million, which is lower than market expectations(1) by approximately £21 million. This is mainly due to lower capital expenditure during the year, consistent with adjustments made to the timing of capital spend as the Turnaround Plan has evolved. Total aggregate 3-year cash investment for the Turnaround Plan remains unchanged.

Due to the positive outcome of the financial year, the Company has repaid all the money received from HM Government's Coronavirus Job Retention Scheme. Furlough payments received under this scheme totalled approximately £0.4m.

In the results for financial year 2020/21, the Company will record non-cash exceptional asset impairment and accelerated depreciation charges of approximately £13 million on historic assets, as a result of the closure of the Gateshead banknote printing operations in December 2020. Of this, approximately £12m was recorded in the second half of the year following finalisation of the detailed plans for which assets currently are expected to have any ongoing use within the group.

De La Rue expects to announce its results for the full year ended 27 March 2021 on 26 May 2021.

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

(1). Market expectations are based on the average of published notes from Investec and Numis Securities.

Enquiries:

 

De La Rue plc

 

+44 (0) 7387 122645

Clive Vacher

 

Chief Executive Officer

Rob Harding

 

Chief Financial Officer

Matthew Rose

 

Director of Tax, Treasury and Investor Relations

 

Brunswick Group LLP +44 (0)207 404 5959

Stuart Donnelly/Ed Brown

 

 

Cautionary note regarding forward-looking statements

 

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "plans", "may", "will", "could", "shall", "risk", "aims", "predicts", "continues", "assumes", "positioned" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the directors, De La Rue or the Group concerning, amongst other things, the results of operations, financial condition, liquidity, prospects, growth and strategies of De La Rue and the industry in which it operates.

By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of the Company. Past performance cannot be relied upon as a guide to future performance and should not be taken as a representation or assurance that trends or activities underlying past performance will continue in the future. Accordingly, investors or potential investors should not place undue reliance on these forward-looking statements. The Group's actual results of operations, financial condition, liquidity and the development of the industry in which it operates may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the results of operations, financial condition and liquidity of the Group and the development of the industry in which it operates, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

Other than in accordance with its legal or regulatory obligations, De La Rue does not undertake any obligation to update these forward-looking statements, which speak only as at the date of this announcement, and will not publicly release any revisions that may be made to these forward-looking statements, which may result from events or circumstances arising after the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTITMRTMTBBBFB
Date   Source Headline
4th Feb 20198:00 amRNSAdditional Listing
31st Jan 20194:47 pmRNSTotal Voting Rights
14th Jan 20192:20 pmEQSEdison issues initiation on De La Rue (DLAR)
8th Jan 20199:00 amRNSAdditional Listing
7th Jan 201912:01 pmRNSDe La Rue PLC - Director/PDMR Shareholding
2nd Jan 201911:10 amRNSBlock listing Interim Review
31st Dec 201812:53 pmRNSHolding(s) in Company
31st Dec 201812:44 pmRNSTotal Voting Rights
19th Dec 20185:02 pmRNSDirector/PDMR Shareholding
14th Dec 20184:44 pmRNSDirector/PDMR Shareholding
30th Nov 20184:57 pmRNSTotal Voting Rights
27th Nov 20187:00 amRNS2018/19 HALF YEAR RESULTS AND STRATEGY UPDATE
6th Nov 20181:08 pmRNSNotice of Half Year Results
31st Oct 20184:43 pmRNSTotal Voting Rights
9th Oct 201810:00 amRNSAdditional Listing
1st Oct 20185:30 pmRNSTotal Voting Rights
10th Sep 20181:32 pmRNSHolding(s) in Company
31st Aug 20184:54 pmRNSTotal Voting Rights
29th Aug 201812:22 pmRNSDirector/PDMR Shareholding
22nd Aug 20184:12 pmRNSHolding(s) in Company
17th Aug 20185:23 pmRNSHolding(s) in Company
16th Aug 20189:30 amRNSAdditional Listing
3rd Aug 20189:27 amRNSDirector/PDMR Shareholding
3rd Aug 20189:00 amRNSAdditional Listing
31st Jul 20184:45 pmRNSTotal Voting Rights
26th Jul 20182:35 pmRNSResult of AGM
26th Jul 201810:30 amRNSAGM Statement
25th Jul 20185:21 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSHolding(s) in Company
19th Jul 20187:00 amRNSDirectorate Change
13th Jul 20185:56 pmRNSDirector/PDMR Shareholding
13th Jul 20185:54 pmRNSDirector/PDMR Shareholding
3rd Jul 201811:41 amRNSDirector/PDMR Shareholding
2nd Jul 20181:57 pmRNSBlock Listing Six Monthly Return
2nd Jul 201812:01 pmRNSTotal Voting Rights
27th Jun 201812:59 pmRNSDirector/PDMR Shareholding
21st Jun 20184:14 pmRNSAnnual Financial Report
19th Jun 20185:40 pmRNSDirector/PDMR Shareholding
14th Jun 20182:25 pmRNSDirector/PDMR Shareholding
12th Jun 20184:04 pmRNSDirector/PDMR Shareholding
4th Jun 20185:25 pmRNSDirector/PDMR Shareholding
31st May 20185:35 pmRNSTotal Voting Rights
30th May 20187:00 amRNS2017/18 FULL YEAR RESULTS
23rd May 20189:38 amRNSNotice of Full Year Results
30th Apr 20183:48 pmRNSTotal Voting Rights
30th Apr 20182:44 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSUpdate on full year outturn & UK passport tender
9th Apr 20185:27 pmRNSHolding(s) in Company
3rd Apr 201810:44 amRNSTotal Voting Rights
29th Mar 20183:19 pmRNSCompletion of paper transaction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.